1. Home
  2. EYPT vs TWI Comparison

EYPT vs TWI Comparison

Compare EYPT & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • TWI
  • Stock Information
  • Founded
  • EYPT 1987
  • TWI 1890
  • Country
  • EYPT United States
  • TWI United States
  • Employees
  • EYPT N/A
  • TWI N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • TWI Steel/Iron Ore
  • Sector
  • EYPT Industrials
  • TWI Industrials
  • Exchange
  • EYPT Nasdaq
  • TWI Nasdaq
  • Market Cap
  • EYPT 427.9M
  • TWI 450.6M
  • IPO Year
  • EYPT 2005
  • TWI 1993
  • Fundamental
  • Price
  • EYPT $6.51
  • TWI $6.86
  • Analyst Decision
  • EYPT Strong Buy
  • TWI Strong Buy
  • Analyst Count
  • EYPT 8
  • TWI 2
  • Target Price
  • EYPT $25.71
  • TWI $11.00
  • AVG Volume (30 Days)
  • EYPT 841.5K
  • TWI 661.2K
  • Earning Date
  • EYPT 05-07-2025
  • TWI 04-30-2025
  • Dividend Yield
  • EYPT N/A
  • TWI N/A
  • EPS Growth
  • EYPT N/A
  • TWI N/A
  • EPS
  • EYPT N/A
  • TWI N/A
  • Revenue
  • EYPT $43,273,000.00
  • TWI $1,845,937,000.00
  • Revenue This Year
  • EYPT N/A
  • TWI $1.14
  • Revenue Next Year
  • EYPT N/A
  • TWI $6.75
  • P/E Ratio
  • EYPT N/A
  • TWI N/A
  • Revenue Growth
  • EYPT N/A
  • TWI 1.32
  • 52 Week Low
  • EYPT $3.91
  • TWI $5.93
  • 52 Week High
  • EYPT $21.26
  • TWI $11.97
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.19
  • TWI 41.95
  • Support Level
  • EYPT $5.37
  • TWI $6.41
  • Resistance Level
  • EYPT $5.86
  • TWI $6.90
  • Average True Range (ATR)
  • EYPT 0.57
  • TWI 0.54
  • MACD
  • EYPT 0.20
  • TWI -0.03
  • Stochastic Oscillator
  • EYPT 99.81
  • TWI 39.74

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: